NeuroBionics

Cambridge, MA · Founded 2023 · Privately Held (backing)

Developer of a neural interface technology designed to enhance the integration of bioelectronics with the human body. NeuroBionics is based in Cambridge, MA and was founded in 2023. It was valued at $33.3 million at its seed round in Dec 2025, the last priced event on record. It has raised $9.3 million across 1 recorded round; the latest was a $4.2 million seed round in Nov 2025.

PMV mark · valuation
$33.3M
Oct 2026
Priced at
its seed round
Dec 2025
Total raised
$9.3M
Last round
Seed Round
Nov 2025
Cap table — not yet on record

NeuroBionics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NeuroBionics with a free account
  • ·The complete investor list: 19 names
  • ·Watch NeuroBionics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about NeuroBionics

Where does NeuroBionics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across NeuroBionics's 1 recorded funding rounds.